Small Business

Johnson & Johnson expands portfolio; launches Neutrogena brand

Health and skin care products maker Johnson & Johnson today announced the launch of its global beauty care brand "Neutrogena" in the domestic market with an aim to be one of the top five companies in India. - Johnson & Johnson Q2 profit dips to $3.2 bn - India can become a global pharma innovation hub: experts - Dabur completes Fem acquisition ; to launch new products - Revlon to slash 400 jobs under cost-cutting initiatives - Dabur plans big expansion in skin care, to launch new brand The company today introduced 22 products in the skin care category and plans to bring in more products from its global portfolio in future. "We have been assessing the Indian skincare market for sometime now and found out that young women are increasingly getting aware about skin protection. So, we felt this is the right time to launch the product or in a way expand our portfolio," J&J Vice-President (Marketing) Tina Mistry told reporters here. She said J&J will keep assessing the market for bringing its other global brand in India "as and when the opportunity arises". "Our plan is to establish the brand in India. We will keep assessing the market but as of now our focus is on our skin care range that we have introduced," Mistry said. She said the company will target to be among the top five skin care brand in India in the next 3-5 years period. The company has already appointed bollywood actress Prachi Desai as the brand ambassador to endorse it products. "We will be going aggressively to be among the top five skin care brands here. We have several marketing activities, lined up," she said. Neutrogena is around 40 years old global brand and offers over 400 products in the international markets.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
83% investors feel economy will recover in next fiscal: Fitch
The Indian economy will recover in the next financial year even as concerns over poor monsoon, drought and fall in exports loom large, a survey says.
Popular Articles

Dr Reddy's to invest Rs 750 crore in two SEZs
Dr Reddy"s Laboratories (DRL), the second largest drug maker in the country, would invest about Rs 750 crore ($ 150 million) in setting up two special economic zones (SEZs)- one in Visakhapatnam and another in Hyderabad.

Time your stock sale
The decision to exit your stock holdings is never easy. But it is important to keep profit-booking for better returns.